About flora growth corp - FLGC
Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: Cultivation, Processing, and Supplying of Natural, Medicinal-Grade Cannabis Oil and High Quality Cannabis, Over-the-Counter Medical Products and Medical Cannabis Products, Wellbeing Products, and Food and Beverage Products. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.
FLGC At a Glance
Flora Growth Corp.
3230 West Commercial Boulevard
Fort Lauderdale, Florida 33309
Phone | 1-954-842-4989 | Revenue | 76.07M | |
Industry | Pharmaceuticals: Other | Net Income | -53,893,000.00 | |
Sector | Health Technology | 2023 Sales Growth | 104.651% | |
Fiscal Year-end | 12 / 2024 | Employees | 108 | |
View SEC Filings |
FLGC Valuation
P/E Current | N/A |
P/E Ratio (with extraordinary items) | N/A |
P/E Ratio (without extraordinary items) | N/A |
Price to Sales Ratio | 0.131 |
Price to Book Ratio | 1.884 |
Price to Cash Flow Ratio | N/A |
Enterprise Value to EBITDA | -1.461 |
Enterprise Value to Sales | 0.121 |
Total Debt to Enterprise Value | 0.398 |
FLGC Efficiency
Revenue/Employee | 704,361.111 |
Income Per Employee | -499,009.259 |
Receivables Turnover | 10.71 |
Total Asset Turnover | 1.454 |
FLGC Liquidity
Current Ratio | 1.312 |
Quick Ratio | 0.79 |
Cash Ratio | 0.269 |
FLGC Profitability
Gross Margin | 2.545 |
Operating Margin | -11.362 |
Pretax Margin | -63.489 |
Net Margin | -70.846 |
Return on Assets | -90.539 |
Return on Equity | -149.803 |
Return on Total Capital | -470.008 |
Return on Invested Capital | -143.427 |
FLGC Capital Structure
Total Debt to Total Equity | 57.339 |
Total Debt to Total Capital | 36.443 |
Total Debt to Total Assets | 15.542 |
Long-Term Debt to Equity | 14.71 |
Long-Term Debt to Total Capital | 9.349 |